Abstract:ABSTRACT Transcriptional activity of RNA polymerase II (Pol II) is influenced by post-translational modifications of the C-terminal domain (CTD) of the largest Pol II subunit, RPB1. Herpes simplex virus type 1 (HSV-1) usurps the cellular transcriptional machinery during lytic infection to efficiently express viral mRNA and shut down host gene expression. The viral immediate-early protein ICP22 interferes with serine 2 phosphorylation (pS2) by targeting CDK9 and other CDKs, but the full functional implications of this are not well understood. Using Western blotting, we report that HSV-1 also induces a loss of serine 7 phosphorylation (pS7) of the CTD during lytic infection, requiring expression of the two immediate-early proteins ICP22 and ICP27. ICP27 has also been proposed to target RPB1 for degradation, but we show that pS2/S7 loss precedes the drop in total protein levels. Cells with the RPB1 polyubiquitination site mutation K1268R, preventing proteasomal degradation during transcription-coupled DNA repair, displayed loss of pS2/S7 but retained higher overall RPB1 protein levels later in infection, indicating this pathway is not involved in early CTD dysregulation but may mediate bulk protein loss later. Using α-amanitin-resistant CTD mutants, we observed differential requirements for Ser2 and Ser7 for the production of viral proteins, with Ser2 facilitating viral immediate-early genes and Ser7 appearing dispensable. Despite dysregulation of CTD phosphorylation and different requirements for Ser2/7, all CTD modifications tested could be visualized in viral replication compartments with immunofluorescence. These data expand the known means that HSV employs to create pro-viral transcriptional environments at the expense of host responses. IMPORTANCE Cells rapidly induce changes in the transcription of RNA in response to stress and pathogens. Herpes simplex virus (HSV) disrupts many processes of host mRNA transcription, and it is necessary to separate the actions of viral proteins from cellular responses. Here, we demonstrate that viral proteins inhibit two key phosphorylation patterns on the C-terminal domain (CTD) of cellular RNA polymerase II and that this is separate from the degradation of polymerases later in infection. Furthermore, we show that viral genes do not require the full “CTD code.” Together, these data distinguish multiple steps in the remodeling of RNA polymerase during infection and suggest that shared transcriptional phenotypes during stress responses do not revolve around a core disruption of CTD modifications.

CK2 phosphorylation of CMTR1 promotes RNA cap formation and influenza virus infection

Inhibition of cellular RNA methyltransferase abrogates influenza virus capping and replication

Mimic Phosphorylation of a Βc1 Protein Encoded by TYLCCNB Impairs Its Functions As a Viral Suppressor of RNA Silencing and a Symptom Determinant.

Cap-related modifications of RNA regulate binding to IFIT proteins

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Herpes simplex virus 1 inhibits phosphorylation of RNA polymerase II CTD serine-7

Structural and functional characterization of the interaction between the influenza A virus RNA polymerase and the CTD of host RNA polymerase II

Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response.

Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding

Methylation of viral mRNA cap structures by PCIF1 attenuates the antiviral activity of interferon-β

Regulation of influenza A virus mRNA splicing by CLK1

RNA Binding Protein CPEB1 Remodels Host and Viral RNA Landscapes

The host RNA polymerase II C-terminal domain is the anchor for replication of the influenza virus genome

Identifying cellular RNA-binding proteins during infection uncovers a role for MKRN2 in influenza mRNA trafficking

A novel and ubiquitous miRNA-involved regulatory module ensures precise phosphorylation of RNA polymerase II and proper transcription

A specific phosphorylation-dependent conformational switch of SARS-CoV-2 nucleoprotein inhibits RNA binding

Coat protein of TCV suppresses RNA decay via ubiquitination and autophagy pathways to facilitate viral infection

N7-Methylation of the Coronavirus RNA Cap Is Required for Maximal Virulence by Preventing Innate Immune Recognition

TBK1-METTL3 axis facilitates antiviral immunity

Coordinate control of the RNA polymerase II transcription cycle by CDK9-dependent, tripartite phosphorylation of SPT5